Towa Pharmaceutical Co., Ltd. (4553.T)

JPY 2808.0

(2.3%)

EBITDA Summary of Towa Pharmaceutical Co., Ltd.

  • Towa Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was 35.53 Billion JPY , up 31.44% from previous year.
  • Towa Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q1 was 10.4 Billion JPY , up 39.85% from previous quarter.
  • Towa Pharmaceutical Co., Ltd. reported an annual EBITDA of 24.92 Billion JPY in 2022, down -14.7% from previous year.
  • Towa Pharmaceutical Co., Ltd. reported an annual EBITDA of 29.49 Billion JPY in 2021, up 0.06% from previous year.
  • Towa Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 4.44 Billion JPY for 2023 Q1, up 346.04% from previous quarter.
  • Towa Pharmaceutical Co., Ltd. reported a quarterly EBITDA of N/A for 2023 FY, up 31.44% from previous quarter.

Annual EBITDA Chart of Towa Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual EBITDA of Towa Pharmaceutical Co., Ltd. (2023 - 2004)

Year EBITDA EBITDA Growth
2023 35.53 Billion JPY 31.44%
2022 24.92 Billion JPY -14.7%
2021 29.49 Billion JPY 0.06%
2020 30.35 Billion JPY 23.23%
2019 24.45 Billion JPY -0.72%
2018 24.62 Billion JPY 21.09%
2017 19.81 Billion JPY 35.41%
2016 15.12 Billion JPY -19.84%
2015 18.46 Billion JPY 8.34%
2014 16.84 Billion JPY 31.44%
2013 13.19 Billion JPY 4.46%
2012 14.32 Billion JPY 5.87%
2011 12.45 Billion JPY 9.99%
2010 11.37 Billion JPY 20.85%
2009 9.15 Billion JPY 9.83%
2008 8.1 Billion JPY 28.36%
2007 6.06 Billion JPY 6.78%
2006 5.7 Billion JPY 41.5%
2005 3.26 Billion JPY 18.62%
2004 3.85 Billion JPY 0.0%

Peer EBITDA Comparison of Towa Pharmaceutical Co., Ltd.

Name EBITDA EBITDA Difference
Pharma Foods International Co., Ltd. 6.02 Billion JPY -490.201%
Takeda Pharmaceutical Company Limited 874.6 Billion JPY 95.937%
Sumitomo Pharma Co., Ltd. -281.07 Billion JPY 112.643%
Shionogi & Co., Ltd. 186.7 Billion JPY 80.966%
Wakamoto Pharmaceutical Co.,Ltd. 570.97 Million JPY -6123.773%
Nippon Shinyaku Co., Ltd. 36.29 Billion JPY 2.078%
Kaken Pharmaceutical Co., Ltd. 12.26 Billion JPY -189.688%
Eisai Co., Ltd. 103.1 Billion JPY 65.534%
Morishita Jintan Co., Ltd. 1.29 Billion JPY -2648.337%
Hisamitsu Pharmaceutical Co., Inc. 18.34 Billion JPY -93.762%
Mochida Pharmaceutical Co., Ltd. 8.97 Billion JPY -296.033%
Fuso Pharmaceutical Industries,Ltd. 3.67 Billion JPY -868.283%
Nippon Chemiphar Co., Ltd. 1.4 Billion JPY -2432.858%
Tsumura & Co. 30.77 Billion JPY -15.482%
Kissei Pharmaceutical Co., Ltd. 18.72 Billion JPY -89.829%
Torii Pharmaceutical Co., Ltd. 5.27 Billion JPY -574.179%
Fuji Pharma Co., Ltd. 6.88 Billion JPY -416.362%
Zeria Pharmaceutical Co., Ltd. 17.52 Billion JPY -102.812%
KYORIN Holdings, Inc. 10.29 Billion JPY -245.144%
Taiko Pharmaceutical Co.,Ltd. -3.75 Billion JPY 1047.627%
Daito Pharmaceutical Co.,Ltd. 7.55 Billion JPY -370.489%
SymBio Pharmaceuticals Limited -714 Million JPY 5077.031%
MedRx Co., Ltd -884.51 Million JPY 4117.564%
Mizuho Medy Co.,Ltd. 5.53 Billion JPY -541.874%
Solasia Pharma K.K. -635 Million JPY 5696.22%
Modalis Therapeutics Corporation -2.37 Billion JPY 1596.931%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.16 Billion JPY -287.821%
Sawai Group Holdings Co., Ltd. 36.87 Billion JPY 3.626%
Cyfuse Biomedical K.K. -538.28 Million JPY 6701.658%
Toho Holdings Co., Ltd. 25.84 Billion JPY -37.497%
Koa Shoji Holdings Co.,Ltd. 5.1 Billion JPY -596.56%